Attached files
| file | filename |
|---|---|
| 10-K - 10-K - TETRALOGIC PHARMACEUTICALS Corp | tlog-20141231x10k.htm |
| EX-31.1 - EX-31.1 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20141231ex311c788b2.htm |
| EX-32.1 - EX-32.1 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20141231ex321d36e65.htm |
| EX-31.2 - EX-31.2 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20141231ex312f78d8d.htm |
| EX-32.2 - EX-32.2 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20141231ex322c7bcad.htm |
| EX-21 - EX-21 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20141231ex21d920052.htm |
| EXCEL - IDEA: XBRL DOCUMENT - TETRALOGIC PHARMACEUTICALS Corp | Financial_Report.xls |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement No. 333-192875 on Form S-8 and No. 333-201346 on Form S-3 of TetraLogic Pharmaceuticals Corporation of our report dated February 26, 2015, with respect to the consolidated financial statements of TetraLogic Pharmaceuticals Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
February 26, 2015